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ABSTRACT.
Purpose: To explore the presence of microvascular endothelial dysfunction as a
measure for early cardiovascular disease in individuals diagnosed with dry eye
disease (DED) as compared to age-matched normal controls.
Methods: Systemic blood pressure, Body Mass Index, intraocular pressure,
blood levels of glucose (GLUC), triglycerides, cholesterol (CHOL), high-density
lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol
(LDL-C)] as well as retinal and peripheral microvascular function were assessed
in twenty-five 35–50 year olds with diagnosed with DEDa (using the TFOS
DEWS II criteria) and 25 age and sex-matched controls.
Results: After controlling all the influential covariates, individuals diagnosed with
DEDexhibited significant lower retinal artery baseline (p = 0.027), arterymaximum
diameter (p = 0.027), minimum constriction (p = 0.039) and dilation amplitude
(p = 0.029) than controls. In addition, the time to reach the vein maximum diameter
was significantly longer in the DED patients than in normal controls (p = 0.0052).
Only in individuals diagnosed with DED, artery maximum constriction correlated
statistically significantly and positively with HDL-C blood levels (p = 0.006).
Similarly, artery slopeAD correlated positively with T-CHOL and LDL-C
(p = 0.006 & 0.011 respectively). Additionally, artery baseline diameter and
maximum constriction were significantly and negatively correlated to T-CHOL/
HDL-C ratio (p = 0.032 and p = 0.013 respectively) in DED individuals only.
Conclusions: Individuals with positive diagnosis of DED exhibit abnormal
retinal microvascular function and possible higher risk for CVD.
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Introduction
Dry eye disease (DED) represents a,
multifactorial, chronic and debilitating
pathology of the ocular surface char-
acterized by loss of homeostasis of the
tear film and accompanied by ocular
symptoms. Tear film instability and
hyperosmolarity, ocular surface inflam-
mation and damage as well as
neurosensory abnormalities play
etiological roles in this disease (Craig
et al. 2017).
In addition to other risk factors,
DED has previously been associated
with dyslipidaemia, a group of meta-
bolic abnormalities characterized by
any or a combination of the following:
raised low-density lipoprotein choles-
terol (LDL-C), raised total cholesterol
(TC), raised triglycerides (TG) and low
high-density lipoprotein cholesterol
(HDL-C) (Musunuru 2010). Indeed,
as lipid homeostasis is important for
the stability of the tear film, the asso-
ciation between dyslipidaemia and
DED is entirely justified. Moreover,
disruptions of cholesterol biosynthesis
are also associated with sebaceous/
Meibomian gland (MG) dysfunctions
(Bu et al. 2019), another cause of tear
film instability and dry eye. Dyslipi-
daemia also represents a significant risk
factor for cardiovascular disease
(CVD) especially due to its contribu-
tion in the pathogenesis of atheroscle-
rosis in medium-sized and large arteries
but also at the microvascular level
(Pereira 2012; Padro, Vilahur & Badi-
mon 2018). This affects not only the
anatomy of these vessels but, most
importantly, their function. Indeed, at
the functional level, it impairs endothe-
lium-dependent vasodilation because
of defects on nitric oxide (NO)
bioavailability (Padro, Vilahur & Badi-
mon 2018). This has catastrophic
effects on the balance between the
physiological vascular dilatory and
constrictory states, which, in turn, will
also affect other important circulatory
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functions and, most importantly, vas-
cular protection against oxidation,
inflammation and thrombosis (Mudau
et al. 2012). This imbalance charac-
terises the so-called endothelial dys-
function (ED), an initial reversible step
in the development of atherogenesis;
nevertheless, it is also one of the most
important stages in the development of
CVD. Therefore, its identification, as
early as possible, represents a key
factor in CVD prevention (Mudau
et al. 2012).
Besides having common risk factors,
other relationships between DED and
CVD are not clearly understood. How-
ever, as both CVD and DED disease
are common and important health
problems encountered frequently in
the general population, a closer look
at their other possible links is war-
ranted. The present study explores the
presence of microvascular ED (as a
measure for early CVD) in individuals




Healthy individuals aged between 35
and 50-year-old were recruited for this
case-control study through advertise-
ments at the Vascular Research Labo-
ratory, and the Dry Eye Clinic, Aston
University (Birmingham, UK). Ethical
approval was sought from the relevant
local ethics committees, and written
informed consent was received from all
participants prior to study enrolment.
The study was designed and conducted
in accordance with the tenets of the
Declaration of Helsinki, and all study-
related procedures adhered to institu-
tional guidelines.
Study exclusion criteria were defined
as the positive diagnosis of hyperten-
sion, CVD, cerebrovascular disease,
peripheral vascular disease, dyslipi-
daemia, diabetes, as well as other
metabolic disorders or chronic diseases
that required treatment. Individuals
using any vasoactive medications were
also excluded from the study. Potential
participants were also screened for
ocular diseases and were excluded from
the study if they had a refractive error
of more than  3DS and more
than  1DC equivalent, intra-ocular
pressure (IOP) >21 mmHg, cataract
or any other media opacities, as well
as history of intra-ocular surgery or
any form of retinal or neuro-oph-
thalmic disease affecting the ocular
vascular system.
Quality of the retinal vascular
images was assessed after the analysis
and participants with poor image qual-
ity was excluded from the study.
General investigations
Standard anthropometric measures of
height and weight were recorded to
determine body mass index
(BMI = weight/height). Systolic blood
pressure (SBP), diastolic blood pres-
sure (DBP), and heart rate (HR) were
measured using an automatic Blood
Pressure monitor (UA-767; A&D
Instruments Ltd, UK) to determine
mean arterial pressure (MAP = 2/3
DBP + 1/3 SBP). Intra-ocular pressure
(IOP) readings were obtained using
non-contact tonometry (Pulsair; Keeler
Ltd, UK).
In addition, blood and plasma sam-
ples drawn from the antecubital fossa
vein were assessed immediately for
fasting GLUC, TG, total cholesterol
(T-CHOL), and HDL-C using the
Reflotron Desktop Analyzer (Roche
Diagnostics, UK). Low-density
lipoprotein cholesterol (LDL-C) values
were calculated as per the Friedewald
equation (Friedewald, Levy &
Fredrickson 1972).
DED diagnosis
All subjects underwent dry eye assess-
ment using a digital slit lamp and the
Keratograph K5m (Oculus, Wetzlar,
Germany) including objective non-in-
vasive breakup time, taking the average
of three readings and ocular surface
staining with fluorescein (i-DEW Flo,
Mainline, Derby, UK) and lissamine
green (GreenGlo, HUB Pharmaceuti-
cals, Plymouth, MI, USA) using the
TFOS DEWS II recommended
methodology (Wolffsohn et al. 2017).
Osmolarity was assessed in each eye
using the Tearlab (Dallas-Fort Worth,
TX, USA).
Diagnosis of dry eye was based on
the latest TFOS DEWS II criteria
(Wolffsohn et al. 2017) which involves
a positive symptoms screening with the
Ocular Surface Disease Index (cut-off
>+13) and one or more of non-invasive
tear breakup time (<10 s), hyperosmo-
larity (>+308 mOsm/l in the higher eye
or an intereye difference .8mIsm/l) and
ocular surface staining (>5 corneal, >9
conjunctival punctate spots or lid
margin (≥2 mm length and >+25%
width).
Dynamic retinal microvascular function
vessel analysis
Retinal microvascular function was
assessed using the dynamic retinal ves-
sel analyser (DVA, IMEDOS GmbH,
Jena, Germany) in accordance with an
established protocol (Nagel, Vilser &
Lanzl 2004) Using a validated in-house
algorithm, the following vessel reactiv-
ity and time-course parameters were
determined: the average baseline diam-
eter and range of maximum and min-
imum baseline vessel diameters
(baseline diameter fluctuation, BDF);
the maximum vessel dilation diameter
during flicker stimulation expressed as
a percentage change relative to baseline
diameter (MD%) and the time taken in
seconds to reach the maximum diam-
eter (tMD); the maximum vessel con-
striction diameter during the
postflicker recovery period expressed
as a percentage change relative to
baseline diameter (MC%) and the time
taken in seconds to reach the maximum
vessel constriction diameter (tMC); the
overall dilation amplitude (DA) calcu-
lated as the difference between MD and
MC; and the baseline-corrected flicker
response (BCFR) used to describe the
overall DA after normalizing for fluc-
tuations in baseline diameters (DA-
BDF). In addition, the arterial (A) and
venous (V) dilation slopes (SlopeAD/
VD = (MD  baseline diameter)/tMD)
and constriction slopes (SlopeAC/
VC = (MC – MD)/tMC) were also cal-
culated (Fig. 1) (Shokr, Dias & Gher-
ghel 2020).
Digital thermal monitoring
The peripheral microvascular function
was assessed using VENDYS
5000 BCE digital thermal monitoring
(DTM) system (Endothelix, Inc, Hous-
ton, TX, USA) according to an estab-
lished protocol (Schier et al. 2013).The
following parameters were measured
and calculated (Fig. 2): temperature
rebound (TR): maximum temperature
(TMAX); minimum temperature (TMIN);
adjusted TR (aTR); and area under the
curve TR. The post-occlusive aTR
determined by the software algorithm
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is directly associated with the extent of
the subjects vascular reactivity. An
aTR below 1 was considered poor
cardiovascular reactivity (high risk),
whereas an aTR between 1 and 2 was
considered intermediate vascular reac-
tivity (medium risk). An aTR of >2 was
considered a sign for normal peripheral
vascular reactivity (Karimzad, Shokr &
Gherghel 2019).
Statistical analysis
Based on previous studies, a change of
30% with a SD of 2.5% in retinal
vessel reactivity was shown to be
significant. As the study design was
multi-factorial in nature it was calcu-
lated that n = 25 in each group was
sufficient to provide 90% power with
an alpha of 0.05.
All data are reported as mean (SD)
unless otherwise indicated. The
Shapiro–Wilk test was used to deter-
mine the distribution of the data.
Univariate associations were deter-
mined using Pearson’s (normally dis-
tributed data) or Spearman’s method
(non-normally distributed data), and
forward stepwise regression analyses
were performed to test the influences of
Fig. 1. Graphical presentation of the dynamic vessel response profile displaying the parameters calculated and used in analysis. (DA) calculated as
(MD  MC). (MD%) calculated as the percent increase from baseline to MD. (MC%) calculated as the percent constriction below baseline following
MD.
Fig. 2. Graphical representation of the Digital Thermal Monitor software analysis; AUCTR = area under the curve temperature rebound;
TMAX = maximum temperature, TMIN = minimum temperature.
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systemic and circulating markers on the
measured variables. In multivariate
regression models the b coefficient
value was considered to answer the
question of which of the independent
variables has a greater effect on the
dependent variable as b refers to the
SD change in the dependent variable
per SD increase in the predictor vari-
able, and is particularly useful when
variables are measured in different
units. Differences between groups were
subsequently assessed using one-way
analysis of variance (ANOVA) or analysis
of covariance (ANCOVA).p-values of
<0.05 were considered significant. All
analyses were performed using Statis-
tica (version 13.3; StatSoft Inc.,
Tusla, OK, USA) software.
Results
A total number of 66 participants were
initially screened for study inclusion, of
which 16 individuals were excluded
based on the quality of retinal vascular
image analysis. The remaining 50 par-
ticipants were included in the final
analysis and classified into two study
groups based on a positive diagnosis
for DED: 25 individuals (12 men and
13 women) and negative diagnosis: 25
individuals (15 men and 10 women).
General characteristics of the study
population are presented in Table 1.
There were no significant differences in
age, sex, BMI, HR, IOP, GLUC, TG,
and LDL-C, between the study groups
(all p > 0.05). Although still within the
normal range, the individuals with
DED had a statistically significant
higher T-CHOL (5.0 versus
4.44 mmol/l) and lower HDL-C (1.21
versus 1.58 mmol/l) values than those
without DED (p = 0.0356 and 0.0137
respectively), albeit close to the upper
limit for these parameters (Table 1).
There were no significant differences
between the study groups with regard
to the peripheral microvascular func-
tion parameters as measured using the
DTM method (all p > 0.05, Table 1).
In addition, after controlling all the
influential covariates identified using
multivariate analysis, there were no
significant differences between the
study groups with regards to the reti-
nal microvascular parameters BDF,
BCFR, MD%, MC%, tMD and
tMC, SlopeAD and SlopeAC (all
p > 0.05, Table 2). However, individ-
uals diagnosed with DED exhibited
significant lower artery baseline diam-
eter, artery MD, MC and DA than
individuals in the non-dry eye group
(p = 0.0269, p = 0.0273, p = 0.0386
and p = 0.0291, respectively, Fig. 3).
In addition, vein tMD was signifi-
cantly longer in the DED patients
than in normal controls (p = 0.0052;
Table 3).
Only in individuals diagnosed with
DED, artery MC correlated statisti-
cally significantly and positively with
HDL-C blood levels (p = 0.006). Sim-
ilarly, artery slopeAD correlated
Table 1. General characteristics of the study population.
Dry eye diagnosis None dry eye p-value
Number 25 25 –
Sex 12 Male : 13 Female 15 Male : 10 Female –
Age (years) 44.1 (2.5) 37.6 (2.5) 0.073
BMI (kg/m2)† 26.03 (1.03) 26.71 (1.03) 0.645
SBP (mmHg) 116.90 (4.96) 120.5 (4.96) 0.611
DBP (mmHg) 68.94 (3.43) 71.3 (3.43) 0.629
HR (bpm) 62.14 (2.10) 66.00 (2.98) 0.366
IOP 13.48 (0.42) 13.31 (0.44) 0.776
GLUC (mmol/l) 4.81 (0.15) 4.54 (0.16) 0.228
TG (mmol/l) 1.01 (0.07) 0.94 (0.07) 0.502
T-CHOL (mmol/l) 5.0 (0.172) 4.44 (0.19) 0.036*
HDL-C (mmol/l) 1.21 (0.109) 1.58 (0.09) 0.014*
LDL-C (mmol/l) 3.15 (0.23) 2.81 (0.23) 0.301
T-CHOL/HDL-C 4.36 (0.377) 3.086 (2.34) 0.020*
aTR 1.52 (0.14) 1.76 (0.14) 0.237
Data are presented as mean (SD) unless otherwise indicated.
aTR = adjusted temperature rebound, BMI = body mass index, DBP = diastolic blood pressure,
GLUC = glucose, HDL-C = high-density lipoprotein cholesterol, HR = heart rate (in beats per
minute), IOP = intraocular pressure, LDL-C = low-density lipoprotein cholesterol, SBP = sys-
tolic blood pressure, T-CHOL = total cholesterol, TG = triglycerides.
* Significant p-values are indicated where p < 0.05 was considered significant.
† Calculated as weight in kilograms divided by height in metres squared.
Table 2. Summary of retinal arterial vascular functional parameters.
Parameter
Mean (SD)
p-valueDry eye None-dry eye
Artery baseline 110.59 (2.52) 112.72 (2.51) 0.027*
Artery-BDF 5.47 (0.47) 5.434 (0.47) 0.954
Artery-DA† 8.29 (0.77) 10.73 (0.77) 0.029*
Artery-BCFR‡ 3.84 (0.51) 4.33 (0.51) 0.502
Artery-MD 118.75 (2.64) 123.28 (2.85) 0.027*
Artery-tMD 16.73 (0.92) 15.67 (0.92) 0.414
Artery-MD% 4.95 (0.54) 5.56 (0.53) 0.434
Artery-MC 109.50 (2.38) 111.67 (2.38) 0.039*
Artery-tMC 23.95 (1.59) 25.71 (1.58) 0.436
Artery-MC% 3.05 (0.38) 3.63 (0.38) 0.287
Artery-SlopeAD
§ 0.41 (0.04) 0.39 (0.043) 0.764
Artery-SlopeAC
¶ 0.52 (0.08) 0.41 (0.085) 0.361
Unless otherwise indicated, all values are expressed in arbitrary units, which approximately
correspond to micrometres (lm) in a normal Gullstrand eye.
Baseline = baseline diameter, BCFR = baseline-corrected flicker response, BDF = baseline diam-
eter fluctuation, DA = dilation amplitude, MC = Maximum constriction, MC% = percentage
constriction below baseline, MD = artery maximum dilation, MD% = percentage change in
diameter from baseline to maximum dilation, SlopeAC = slope of arterial constriction,
SlopeAD = slope of arterial dilation, tMC = reaction time to maximum constriction diameter
from maximum dilation diameter, tMD = reaction time to maximum dilation diameter.
* Significant p-values are indicated where p < 0.05 was considered significant.
† Calculated as MD  MC.
‡ Calculated as DA  BDF (Nagel, Vilser & Lanzl 2004).
§ Calculated as (MD  baseline)/tMD (Mroczkowska et al. 2012).
Calculated as (MC  MD)/tMC (Mroczkowska et al. 2012).
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positively with T-CHOL and LDL-C
(p = 0.006 & 0.011 respectively). Addi-
tionally, artery baseline diameter and
MC were significantly and negatively
correlated to T-CHOL/HDL-C ratio
(p = 0.032 and p = 0.013 respectively)
in DED individuals only (Fig. 4).
Discussion
This study examined the link between
DED and CVD risk, as assessed using
known circulatory markers as well as
measurements of microvascular func-
tion at the retinal and peripheral level.
Through this approach, it identified
that individuals diagnosed with DED
exhibit abnormal retinal, but not
peripheral microvascular function and
these abnormalities correlate with
plasma levels of circulating choles-
terols. To our knowledge, this is the
first study to reveal that middle-aged
individuals with DED have increased
retinal microvascular dysfunction com-
pared to normal, sex and age-matched
controls.
Similar to other research (Dao et al.
2010; Wang et al. 2012; Chun et al.
2013), this study also demonstrated that
individuals with DED exhibit higher,
albeit at the upper normal levels of
circulating T-CHOL when compared to
those without DED. It has been previ-
ously proposed that the relationship
between hypercholesterolemia and DED
can be explained as increased levels of
cholesterol in the meibomian lipid would
increase its melting point, thus leading
to increased viscosity and plugging of
the meibomian orifice (Butovich, Millar
& Ham 2008). It is also important to
note that individuals with DED included
in our study also exhibited statistically
significant lower, albeit still normal
levels of HDL-C and higher T-CHOL/
HDL-C ratio than the normal controls
group. It is well known that HDL-C
transports cholesterol from the tissues to
the liver to be disposed, making it
beneficial in the prevention of CVD.
Moreover, decreases in HDL-C have
also been linked with ED and a
Table 3. Summary of retinal venous vascular function parameters.
Parameter
Mean (SD)
p-valueDry eye None-dry eye
Vein-baseline 133.62 (3.92) 139.94 (3.92) 0.260
Vein-BDF 5.37 (0.43) 5.23 (0.43) 0.822
Vein-DA† 9.11 (0.61) 8.96 (0.62) 0.867
Vein-BCFR‡ 3.73 (0.43) 3.72 (0.43) 0.988
Vein-MD 140.04 (4.58) 149.92 (4.58) 0.134
Vein-tMD 19.46 (0.70) 16.40 (0.70) 0.005*
Vein-MD% 4.94 (0.38) 4.50 (0.38) 0.415
Vein MC 130.94 (4.35) 140.96 (4.35) 0.110
Vein-tMC 33.49 (1.61) 33.29 (1.61) 0.930
Vein-MC% 2.0 (0.19) 1.76 (0.19) 0.371
Vein-slopeAD
§ 0.49 (0.07) 0.48 (0.07) 0.908
Vein-slopeVC
¶ 0.52 (0.08) 0.41 (0.086) 0.361
Unless otherwise indicated, all values are expressed in arbitrary units, which approximately
correspond to micrometres (lm) in a normal Gullstrand eye.
Baseline = baseline diameter, BCFR = baseline-corrected flicker response, BDF = baseline diam-
eter fluctuation, DA = dilation amplitude, MC = Maximum constriction, MC% = percentage
constriction below baseline, MD = vein maximum dilation, MD% = percentage change in
diameter from baseline to maximum dilation, SlopeVC = slope of venous constric-
tionSlopeVD = slope of venous dilation, tMC = reaction time to maximum constriction diameter
from maximum dilation diameter, tMD = reaction time to maximum dilation diameter.
* Significant p-values are indicated where p < 0.05 was considered significant.
† Calculated as MD  MC.
‡ Calculated as DA  BDF (Nagel, Vilser & Lanzl 2004).
§ Calculated as (MD  baseline)/tMD (Mroczkowska et al. 2012).
Calculated as (MC  MD)/tMC (Mroczkowska et al. 2012).
Fig. 3. Comparison of retinal arterial response profile across groups. AU = arbitrary units, BDF = baseline diameter fluctuation calculated as the
maximum range in vessel diameter during first 30 s of baseline readings, MD% = calculated as the percentage change in vessel diameter from baseline
to maximum following onset of flicker, slopeAC = calculated as (MC – MD)/(tMC), tMC = time to reach maximum constriction post flicker,
tMD = time to reach maximum diameter during flicker.
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reduction in the bioavailability of NO
(Campbell & Genest 2013). In addition,
T-CHOL/HDL-C ratio has previously
been specified as a better indicator of
premature CVD risk in than T-CHOL
levels (Tewari et al. 2005), making these
observations very important.
The present study revealed a novel
finding that, independent of other
characteristic, individuals with DED
exhibit abnormal retinal arterial and
venous microvascular dysfunction. To
date, little research looked at microves-
sels in individuals with DED and only
at the level of conjunctival vessels. It is
HDL-C vs. Artery-MC 
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Fig. 4. Correlation between retinal arterial responses and systemic blood lipids. Arterial maximum constriction, Artery- MC = Arterial maximum
constriction, Artery- MC, Artery- SlopeAD = slope of arterial dilation, Artery-BL = artery baseline diameter, HDL-C = high density lipoprotein
cholesterol, LDL-C = low density lipoprotein cholesterol, T-CHOL = total cholesterol, T-CHOL/HDL = total cholesterol/high density lipoprotein
ratio. Normalized unit values used on y-axes.
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interesting to mention that patients
with DED have been previously shown
to exhibit abnormal microvascular
response and reduced blood flow at
the conjunctival vessels level after
trigeminal stimulation, suggesting that
these patients suffer of an imbalance in
the autonomic nervous system (ANS)
(Chen et al. 2017). Indeed, conjunctival
vessels have a dual autonomic innerva-
tion (Ruskell 1985). Moreover, DED
has been proposed to be associated
with various ANS dysfunctions as
autonomic nerves are abundant in
MG tissue and play an important role
in regulating the secretory activities of
MG in animals (LeDoux et al. 2001; Li
et al. 2012). Endothelial dysfunction
(ED) and ANS imbalance often co-
exist in the development of various
CVD processes (Amiya, Watanabe &
Komuro 2014). At the retinal
microvascular level, in the absence of
autonomic innervation, metabolic and
myogenic stimuli are more involved in
retinal autoregulation of the microvas-
cular calibre (Kur et al., 2012).
Although the function of retinal
microvessels are not under the influ-
ence of ANS, this study suggests that
both the ANS and endothelial dysreg-
ulation co-exist in individuals with
DED and the results of this imbalance
are evident and can be measurable at
different vascular levels. In addition,
abnormalities in the retinal venous
functionality have also been found in
the DED group. Since retinal veins
typically incite a more passive regula-
tory contribution to increases in blood
flow whether this observation may
reflect some kind of reconciliation of
alterations in arterial outflow to the
venous side via downstream autoregu-
latory mechanisms (Kotliar et al. 2004)
is unclear at present.
The positive correlation between the
retinal microvascular function parame-
ters and the levels of circulating HDL-C
in DED individuals reinforces the fact
that the HDL-C has an important role
in prevention of CVD. Indeed, retinal
vascular calibres have been shown to be
independently associated with risk fac-
tor variables such as age, blood pres-
sure, HDL-C, and LDL-C. Our DED
group, however, also exhibited negative
relationship between T- CHOL/HDL-C
ratio and retinal artery MC. As this
circulatory parameter is a strong indi-
cator of risk for CVD (Davidson et al.
2008; Agirbasli et al. 2015), this
observation is very important and, in
addition to the above mentioned micro-
circulatory abnormalities, points to the
fact that DED individuals could exhibit
higher risk for CVD than age- and sex-
matched normal individuals. Further
follow-up studies, to confirm the actual
development of CVD in these individu-
als, are warranted.
Conclusion
Significant attenuations in retinal vas-
cular function exist and can be detected
in persons diagnosed with DED. More-
over, these abnormalities correlate with
known circulatory markers for CVD.
Functional retinal assessments could
therefore be useful for early vascular
screening, possibly contributing to a
reduced risk for CVD morbidity in
these individuals.
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